최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Neurology, v.55 no.10, 2000년, pp.1497 - 1505
Chabot, S. (From the Departments of Oncology (Dr. Yong) and Clinical Neurosciences (Drs. Chabot and Yong), University of Calgary, Alberta, Canada.) , Yong, V.W. (From the Departments of Oncology (Dr. Yong) and Clinical Neurosciences (Drs. Chabot and Yong), University of Calgary, Alberta, Canada.)
초록이 없습니다.
Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis : I. Clinical results of a multicenter, randomized, double‐blind, placebo-controlled trial. Neurology, vol.43, no.4, 655-655.
Interferon beta‐lb in the treatment of multiple sclerosis : Final outcome of the randomized controlled trial. Neurology, vol.45, no.7, 1277-1285.
10.1212/WNL.43.4.662 Paty DW Li DKB UBC MS/MRI Study Group IFN Multiple Sclerosis Study Group. Interferon-beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter randomized double-blind placebo-controlled trial. Neurology 1993;43:662-667.
Rudick, R. A., Goodkin, D. E., Jacobs, L. D., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Granger, C. V., Simon, J. H., Alam, J. J., Simonian, N. A., Campion, M. K., Bartoszak, D. M., Bourdette, D. N., Braiman, J., Brownscheidle, C. M., Coats, M. E., Cohan, S. L., Dougherty, D. S., Kinkel, R. P., Mass, M. K., Munschauer, F. E., Priore, R. L., Pullicino, P. M., Scherokman, B. J., Weistock-Guttman, B., Whitham, R. H.. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. Neurology, vol.49, no.2, 358-363.
Jacobs, Lawrence D., Cookfair, Diane L., Rudick, Richard A., Herndon, Robert M., Richert, John R., Salazar, Andres M., Fischer, Jill S., Goodkin, Donald E., Granger, Carl V., Simon, Jack H., Alam, John J., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munschauer III, Frederick E., Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Weinstock‐Guttman, Bianca, Whitham, Ruth H.. Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis. Annals of neurology, vol.39, no.3, 285-294.
Neurology 582 51 1998 Yong VW, Chabot S, Stuve O, et al. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology . 1998; 51: 582-589.
Rep, Martin H.G., Hintzen, Rogier Q., Polman, Chris H., van Lier, RenéA.W.. Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. Journal of neuroimmunology, vol.67, no.2, 111-118.
Calabresi, P. A., Pelfrey, C. M., Tranquill, L. R., Maloni, H., McFarland, H. F.. VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta. Neurology, vol.49, no.4, 1111-1116.
Lab Invest 1015 79 1999 Lou J, Gasche Y, Zheng L, et al. Interferon-beta inhibits activated leukocyte migration through brain microvascular endothelial cell monolayer. Lab Invest . 1999; 79: 1015-1025.
Stüve, Olaf, Dooley, Nora P., Uhm, Joon H., Antel, Jack P., Francis, Gordon S., Yong, Voon Wee, Williams, Gary. Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9. Annals of neurology, vol.40, no.6, 853-863.
Leppert, David, Waubant, Emmanuelle, Bürk, Martin R., Oksenberg, Jorge R., Hauser, Stephen L.. Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis. Annals of neurology, vol.40, no.6, 846-852.
Rep, Martin H.G, Schrijver, Hans M, van Lopik, Thea, Hintzen, Rogier Q, Roos, Marijke T.L, Adèr, Herman J, Polman, Chris H, van Lier, René A.W. Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients. Journal of neuroimmunology, vol.96, no.1, 92-100.
Sharief, Mohammad K., Hentges, Romain. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis. The New England journal of medicine, vol.325, no.7, 467-472.
Selmaj, K, Raine, C S, Cannella, B, Brosnan, C F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.. The Journal of clinical investigation, vol.87, no.3, 949-954.
Huang, Wen-Xin, Huang, Ping, Link, Hans, Hillert, Jan. Cytokine analysis in multiple sclerosis by competitive RT - PCR: A decreased expression of IL-10 and an increased expression of TNF-&agr; in chronic progression. Multiple sclerosis journal: clinical and laboratory research, vol.5, no.5, 342-348.
10.1002/1531-8249(199906)45:6<695::AID-ANA3>3.0.CO;2-R
Rohowsky-Kochan, C, Molinaro, D, Choudhry, A, Kahn, M, Cook, S D. Impaired interleukin-12 production in multiple sclerosis patients. Multiple sclerosis journal: clinical and laboratory research, vol.5, no.5, 327-334.
10.1002/1531-8249(199902)45:2<247::AID-ANA16>3.0.CO;2-U
Gayo, A., Mozo, L., Suárez, A., Tuñón, A., Lahoz, C., Gutiérrez, C.. Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS. Neurology, vol.52, no.9, 1764-1764.
Brod, S. A., Marshall Jr., G. D., Henninger, E. M., Sriram, S., Khan, M., Wolinsky, J. S.. Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology, vol.46, no.6, 1633-1638.
Özenci,, Kouwenhoven,, Huang,, Xiao,, Kivisäkk,, Fredrikson,, Link,. Multiple Sclerosis: Levels of Interleukin‐10‐Secreting Blood Mononuclear Cells are Low in Untreated Patients but Augmented During Interferon‐β‐1b Treatment. Scandinavian journal of immunology, vol.49, no.5, 554-561.
Rudick, R. A., Ransohoff, R. M., Lee, J. C., Peppler, R., Yu, M., Mathisen, P. M., Tuohy, V. K.. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology, vol.50, no.5, 1294-1300.
Acta Neurol Belg 11 99 1999 Monteyne P, van Antwerpen MP, Sindic CJ. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients. Acta Neurol Belg . 1999; 99: 11-20.
Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. The Journal of experimental medicine, vol.165, no.4, 1058-1075.
Cross, Anne H., O'Mara, Thomas, Raine, Cedric S.. Chronologic localization of myelin‐reactive cells in the lesions of relapsing EAE : Implications for the study of multiple sclerosis. Neurology, vol.43, no.5, 1028-1028.
Chabot, S, Williams, G, Yong, V W. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.. The Journal of clinical investigation, vol.100, no.3, 604-612.
Williams, Kenneth, Bar-Or, Amit, Ulvestad, Elling, Olivier, Andre, Antel, Jack P., Yong, Voon Wee. Biology of Adult Human Microglia in Culture: Comparisons with Peripheral Blood Monocytes and Astrocytes. Journal of neuropathology and experimental neurology, vol.51, no.5, 538-549.
Lab Invest 465 67 1992 Lee SC, Liu W, Brosnan CF, et al. Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. Lab Invest . 1992; 67: 465-476.
Chabot, Sophie, Williams, Gary, Hamilton, Mark, Sutherland, Garnette, Yong, V. Wee. Mechanisms of IL-10 Production in Human Microglia-T Cell Interaction. The journal of immunology : official journal of the American Association of Immunologists, vol.162, no.11, 6819-6828.
Sheng, W S, Hu, S, Kravitz, F H, Peterson, P K, Chao, C C. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro. Clinical and diagnostic laboratory immunology, vol.2, no.5, 604-608.
10.4049/jimmunol.149.7.2378 Yssel H De Waal Malefyt R Roncarolo MG et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-2784.
Acta Neurol Scand 92 100 1999 Mena E, Rohowsky-Kochan C. Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis. Acta Neurol Scand . 1999; 100: 92-96.
10.1146/annurev.iy.11.040193.001121 Moore KW O’Garra A de Waal Malefyt R et al. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
Sawada, Makoto, Suzumura, Akio, Hosoya, Hiromi, Marunouchi, Tohru, Nagatsu, Toshiharu. Interleukin‐10 Inhibits Both Production of Cytokines and Expression of Cytokine Receptors in Microglia. Journal of neurochemistry, vol.72, no.4, 1466-1471.
Koppelman, B., Neefjes, J.J., de Vries, J.E., de Waal Malefyt, R.. Interleukin-10 Down-Regulates MHC Class II αβ Peptide Complexes at the Plasma Membrane of Monocytes by Affecting Arrival and Recycling. Immunity, vol.7, no.6, 861-871.
10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T
Ding, L, Linsley, P S, Huang, L Y, Germain, R N, Shevach, E M. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression.. The journal of immunology : official journal of the American Association of Immunologists, vol.151, no.3, 1224-1234.
Kawamura, Tatsuyoshi, Furue, Masutaka. Comparative analysis of B7‐1 and B7‐2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. European journal of immunology, vol.25, no.7, 1913-1917.
Iglesias, Begoña Menèndez, Cerase, Joanna, Ceracchini, Cristiano, Levi, Giulio, Aloisi, Francesca. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. Journal of neuroimmunology, vol.72, no.1, 83-93.
Akdis, Cezmi A., Blaser, Kurt. IL‐10‐induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.13, no.6, 603-609.
Int Immunol 1605 10 1994 Becker JC, Czerny C, Brocker EB. Maintenance of clonal anergy by endogeneously produced IL-10. Int Immunol . 1994; 10: 1605-1612.
Samoilova, Elena B., Horton, Jennifer L., Chen, Youhai. Acceleration of Experimental Autoimmune Encephalomyelitis in Interleukin-10-Deficient Mice: Roles of Interleukin-10 in Disease Progression and Recovery. Cellular immunology, vol.188, no.2, 118-124.
Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W.. Interleukin-10-deficient mice develop chronic enterocolitis. Cell, vol.75, no.2, 263-274.
Sedgwick, Jonathon D., Ford, Andrew L., Foulcher, Eléna, Airriess, Rhonda. Central Nervous System Microglial Cell Activation and Proliferation Follows Direct Interaction with Tissue-Infiltrating T Cell Blasts. The journal of immunology : official journal of the American Association of Immunologists, vol.160, no.11, 5320-5330.
Raivich, Gennadij, Jones, Leonard L., Kloss, Christian U. A., Werner, Alexander, Neumann, Harald, Kreutzberg, Georg W.. Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration. The Journal of neuroscience : the official journal of the Society for Neuroscience, vol.18, no.15, 5804-5816.
Science 308 218 1983 Traugott U, Reinherz EL, Raine CS. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science . 1983; 218: 308-310.
Kozovska, M.E., Hong, J., Zang, Y.C. Q., Li, S., Rivera, V.M., Killian, J.M., Zhang, J.Z.. Interferon beta induces T-helper 2 immune deviation in MS. Neurology, vol.53, no.8, 1692-1692.
Grumbach, Isabella M., Fish, Eleanor N., Uddin, Shahab, Majchrzak, Beata, Colamonici, Oscar R., Figulla, Hans R., Heim, Albert, Platanias, Leonidas C.. Activation of the Jak-Stat Pathway in Cells That Exhibit Selective Sensitivity to the Antiviral Effects of IFN-beta Compared with IFN-alpha. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, vol.19, no.7, 797-801.
Kanda, Naoko. Gangliosides GD1a and GM3 Induce Interleukin-10 Production by Human T Cells. Biochemical and biophysical research communications, vol.256, no.1, 41-44.
Eigler, Andreas, Siegmund, Britta, Emmerich, Uta, Baumann, Klaus H, Hartmann, Gunther, Endres, Stefan. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. Journal of leukocyte biology, vol.63, no.1, 101-107.
Yoshikawa, Minka, Suzumura, Akio, Tamaru, Tsukasa, Takayanagi, Tetsuya, Sawada, Makato. Effects of phosphodiesterase inhibitors on cytokine production by microglia. Multiple sclerosis journal: clinical and laboratory research, vol.5, no.2, 126-133.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.